3 results
Approved WMOCompleted
Primary: Antiviral efficacy of dolutagravir in combination with Kivexa (abacavir en lamivudine) after 48 weeks of treatment in comparison with Atripla (tenofovir, emtricitabine and efavirenz). Secondary: Antiviral efficacy after 96 and 144 weeks,…
Pending
The purpose of the study is to determine whether PICSO is safe and feasible using a femoral approach, and in what amount of cases PICSO is effective to increase collateral flow index (CFI).
Approved WMOPending
Evaluating the long term safety and tolerability of ranibizumab treatment of AMD patients.